Low‑burden FL: rituximab versus bispecifics trial

Featuring perspectives from Dr Matthew Lunning and Dr Sonali M Smith, including the following topics:

• Which Driver and Which Race: CAR-T and Bispecific Antibodies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Dr Lunning (0:00)
• Available and Emerging Novel Therapies for Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Dr Smith (32:37)

CE information and select publications